Dec 9, 2019 • 8:05 am EST Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System
Nov 18, 2019 • 8:17 am EST Corbus Pharmaceuticals Completes Enrollment of Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Nov 12, 2019 • 8:05 am EST Corbus Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference in London
Nov 11, 2019 • 8:05 am EST Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
Nov 7, 2019 • 7:05 am EST Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
Nov 4, 2019 • 8:05 am EST Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2019 Operational and Financial Results on November 7, 2019
Oct 3, 2019 • 8:05 am EDT Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2019 ACR Annual Meeting
Aug 8, 2019 • 7:05 am EDT Corbus Pharmaceuticals Reports 2019 Second Quarter Financial Results and Provides Clinical and Corporate Updates
Aug 1, 2019 • 8:05 am EDT Corbus Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2019 Operational and Financial Results on August 8, 2019